I
Ivo Paclt
Researcher at Charles University in Prague
Publications - 35
Citations - 2074
Ivo Paclt is an academic researcher from Charles University in Prague. The author has contributed to research in topics: Attention deficit hyperactivity disorder & Population. The author has an hindex of 19, co-authored 35 publications receiving 1935 citations. Previous affiliations of Ivo Paclt include First Faculty of Medicine, Charles University in Prague.
Papers
More filters
Journal ArticleDOI
Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).
Herbert Y. Meltzer,Larry Alphs,Alan I. Green,A. Carlo Altamura,Ravi Anand,Alberto Bertoldi,Marc Bourgeois,Guy Chouinard,M. Zahur Islam,John M. Kane,Ranga Krishnan,Jean-Pierre Lindenmayer,Steven G. Potkin,Saide Altinsan,Siemion Altman,Likiana Avigo,Richard Balon,Vanda Benešová,Luis Bengochea,István Bitter,Elisabeth Bokowska,Bernardo Carpiniello,Daniel E. Casey,Giovanni B. Cassano,James C.-Y. Chou,Libor Chvila,Jean Dalery,Pedro L. Delgado,Liliana Dell'Osso,Carl Eisdorfer,Robin Emsley,Dawn Eng,Tom A. Fahy,Vera Folnegovic,Sophie Frangou,Pedro Gargoloff,Alberto Giannelli,Ira D. Glick,Richard Greenberg,George T. Grossberg,Doris Gundersen,Hannale Heila,George Hsu,Naveed Iqbal,Miro Jakovljević,Richard C. Josiassen,Akos Kassaifarkas,Robert Kerwin,Frederic Khidichian,Mary Ann Knesevich,Jack S. Krasuski,Vinod Kumar,Veronica W. Larach,Michael D. Lesem,Shôn Lewis,Pierre-Michel Llorca,H. Edward Logue,Stephen Martin,Muriel Maurel-Raymondet,Laszlo Mod,Eva Morik,Carlos Morra,Ann M. Mortimer,Mojtaba Noursalehi,Gyorgy Ostorharics-Horvath,Ivo Paclt,Jörg Pahl,Linda Pestreich,J. L. Peters,Rosario Pioli,Michael G. Plopper,Thomas Posever,Mark Hyman Rapaport,Delbert Robinson,Carlo Andrea Robotti,Harry Rohme,Frédéric Rouillon,David A. Sack,Isaac Sakinsofsky,Phillip Seibel,George M. Simpson,Nancy Temkin,Oladapo Tomori,Santha Vaidain,Zdeòka Vyhnándová,Frederick Young,Daniel L. Zimbroff,Marie Agathe Zimmerman +87 more
TL;DR: It is suggested that clozapine therapy significantly reduces suicidal behavior in patients with schizophrenia and schizoaffective disorder at high risk for suicide, and use of clozAPine in this population should lead to a significant reduction in suicidal behavior.
Journal ArticleDOI
Predicting suicidal risk in schizophrenic and schizoaffective patients in a prospective two-year trial
Steven G. Potkin,Larry Alphs,Chuanchieh Hsu,K. Ranga Rama Krishnan,Ravi Anand,Frederick Young,Herbert Y. Meltzer,Alan I. Green,Saide Altinsan,Siemion Altman,Likiana Avigo,Richard Balon,Vanda Benešová,Luis Bengochea,István Bitter,Elisabeth Bokowska,Bernardo Carpiniello,Daniel E. Casey,Giovanni B. Cassano,James C.-Y. Chou,Guy Chouinard,Libor Chvila,Jean Dalery,Pedro L. Delgado,Liliana Dell'Osso,Carl Eisdorfer,Robin Emsley,Thomas Fahy,Vera Folnegovic,Sophie Frangou,Pedro Gargoloff,Alberto Giannelli,Ira D. Glick,Richard Greenberg,George T. Grossberg,Doris Gundersen,Hannale Heila,George Hsu,Naveed Iqbal,Miro Jakovljević,Richard C. Josiassen,Akos Kassaifarkas,Robert Kerwin,Frederic Khidichian,Mary Ann Knesevich,Jack S. Krasuski,Vinod Kumar,Veronica W. Larach,Michael D. Lesem,Shôn Lewis,Pierre Michel Llorca,H. Edward Logue,Stephen Martin,Muriel Maurel-Raymondet,Laszlo Mod,Eva Morik,Carlos Morra,Ann M. Mortimer,Mojtaba Noursalehi,Gyorgy Ostorharics-Horvath,Ivo Paclt,Jörg Pahl,J. L. Peters,Rosario Pioli,Michael G. Plopper,Thomas Posever,Mark Hyman Rapaport,Delbert Robinson,Carlo Andrea Robotti,Frédéric Rouillon,David A. Sack,Isaac Sakinsofsky,Phillip Seibel,George M. Simpson,Nancy Temkin,Oladapo Tomori,Santha Vaidain,Zdeòka Vyhnándová,Daniel L. Zimbroff,Marie Agathe Zimmerman +79 more
TL;DR: Clozapine was more effective than olanzapine in decreasing the risk of suicidality, regardless of risk factors present, and assessment of these risk factors may aid clinicians in evaluating risk for suicidal behaviors so that appropriate interventions can be made.
Journal ArticleDOI
The InterSePT scale for suicidal thinking reliability and validity.
Jean-Pierre Lindenmayer,Jean-Pierre Lindenmayer,Jean-Pierre Lindenmayer,Pál Czobor,Larry Alphs,Ann Marie Nathan,Ann Marie Nathan,Ravi Anand,Zahur Islam,James C Y Chou,James C Y Chou,Saide Altinsan,Saide Altinsan,Siemion Altman,Likiana Avigo,Richard Balon,Vanda Beněsová,Luis Bengochea,Alberto Bertoldi,Elisabeth Bokowska,Marc Bourgeois,Bernardo Carpiniello,James C.-Y. Chou,James C.-Y. Chou,Guy Chouinard,Libor Chvila,Jean Dalery,Liliana Dell'Osso,Carl Eisdorfer,Robin Emsley,Thomas Fahy,Vera Folnegovic,Sophie Frangou,Pedro Gargoloff,Alberto Giannelli,Alan I. Green,Richard Greenberg,George T. Grossberg,George Hsu,Naveed Iqbal,Miro Jakovljević,Richard C. Josiassen,Akos Kassaifarkas,Frederic Khidichian,Mary Ann Knesevich,Jack S. Krasuski,Veronica W. Larach,Michael D. Lesem,Pierre-Michel Llorca,Jean-Pierre Lindenmayer,Stephen Martin,Muriel Maurel-Raymondet,Herbert Y. Meltzer,Laszlo Mod,Eva Morik,Carlos Morra,Ann M. Mortimer,Gyorgy Ostorharics-Horvath,Ivo Paclt,Jörg Pahl,J. L. Peters,Rosario Piolo,Michael G. Plopper,Thomas Posever,Delbert Robinson,Carlo Andrea Robotti,Oladapo Tomori,Santha Vaidain,Zdeòka Vyhnándová,Marie Agathe Zimmerman +69 more
TL;DR: The ISST is a reliable and valid instrument for the assessment of current suicidal thinking in patients with schizophrenia and schizoaffective disorder by both clinicians and researchers.
Journal ArticleDOI
Identification of PIK3C3 promoter variant associated with bipolar disorder and schizophrenia.
Pavla Stopkova,Takuya Saito,Demitri F. Papolos,Jan Vevera,Ivo Paclt,Ilja Zukov,Yonina B Bersson,Benjamin Margolis,Rael D. Strous,Herbert M. Lachman +9 more
TL;DR: A promoter mutation in a PI regulator affecting the binding of a POU-type transcription factor may be involved in BD and SZ in a subset of patients.
Journal ArticleDOI
Sleep disorders and daytime sleepiness in children with attention-deficit/hyperactivity disorder: a two-night polysomnographic study with a multiple sleep latency test.
TL;DR: After the inclusion of adaptation night and exclusion of psychiatric comorbidities, PSG showed no changes in basic sleep parameters or sleep timing, or in the frequency of sleep disorders (SDB, PLMS) in children with ADHD compared with controls, thus not supporting the hypothesis that specific changes in the sleep macrostructure and sleep disturbances are connected with ADHD.